Scholars@Duke publication: Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results

Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results

Publication , Journal Article

Kereiakes, DJ; Lincoff, AM; Miller, DP; Tcheng, JE; Weisman, HF; Topol, EJ

Published in: CIRCULATION

October 21, 1997

CIRCULATION

0009-7322

October 21, 1997

906 / 906

AMER HEART ASSOC

APA

Chicago

ICMJE

MLA

NLM

Kereiakes, D. J., Lincoff, A. M., Miller, D. P., Tcheng, J. E., Weisman, H. F., & Topol, E. J. (1997). Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results. CIRCULATION, 96(8), 906–906.

Kereiakes, D. J., A. M. Lincoff, D. P. Miller, J. E. Tcheng, H. F. Weisman, and E. J. Topol. “Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results.” CIRCULATION 96, no. 8 (October 21, 1997): 906–906.

Kereiakes DJ, Lincoff AM, Miller DP, Tcheng JE, Weisman HF, Topol EJ. Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results. CIRCULATION. 1997 Oct 21;96(8):906–906.

Kereiakes, D. J., et al. “Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results.” CIRCULATION, vol. 96, no. 8, AMER HEART ASSOC, Oct. 1997, pp. 906–906.

Kereiakes DJ, Lincoff AM, Miller DP, Tcheng JE, Weisman HF, Topol EJ. Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results. CIRCULATION. AMER HEART ASSOC; 1997 Oct 21;96(8):906–906.

CIRCULATION

0009-7322

October 21, 1997

906 / 906

AMER HEART ASSOC